Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global ECG Equipment And Management Systems Market, By Type
7.1. ECG Equipment And Management Systems Market, By Type, 2020-2030
7.1.1. Holter Monitors
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Resting ECG System
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Stress ECG Monitors
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Event Monitoring Systems
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. ECG Management Systems
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global ECG Equipment And Management Systems Market, By End-use
8.1. ECG Equipment And Management Systems Market, By End-use, 2020-2030
8.1.1. Hospitals & Clinics
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Ambulatory Facilities
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global ECG Equipment And Management Systems Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Type (2016-2030)
9.1.2. Market Revenue and Forecast, By End-use (2016-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Type (2016-2030)
9.1.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Type (2016-2030)
9.1.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Type (2016-2030)
9.2.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Type (2016-2030)
9.2.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Type (2016-2030)
9.2.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Type (2016-2030)
9.2.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Type (2016-2030)
9.2.6.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Type (2016-2030)
9.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Type (2016-2030)
9.3.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Type (2016-2030)
9.3.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Type (2016-2030)
9.3.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Type (2016-2030)
9.3.6.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Type (2016-2030)
9.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Type (2016-2030)
9.4.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Type (2016-2030)
9.4.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Type (2016-2030)
9.4.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Type (2016-2030)
9.4.6.2. Market Revenue and Forecast, By End-use (2016-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Type (2016-2030)
9.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Type (2016-2030)
9.5.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Type (2016-2030)
9.5.4.2. Market Revenue and Forecast, By End-use (2016-2030)
Chapter 10. Company Profiles
10.1. GE Healthcare
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Nihon Kohden Corporation.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. BioTelemetry, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. CompuMed, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Schiller AG
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Mindray Medical
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Hill Rom
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Koninklijke Philips N.V.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Spacelabs Healthcare
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. McKesson Corporation
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Drägerwerk AG & Co. KGaA
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Mindray Bio-Medical Electronics Co., Ltd.
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Meditech Equipment Co., Ltd.
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
10.14. CardioComm Solutions, Inc.
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives
10.15. Device Technologies
10.15.1. Company Overview
10.15.2. Product Offerings
10.15.3. Financial Performance
10.15.4. Recent Initiatives
10.16. Meditech Equipment Co., Ltd.
10.16.1. Company Overview
10.16.2. Product Offerings
10.16.3. Financial Performance
10.16.4. Recent Initiatives
10.17. ZOLL Medical Corporation
10.17.1. Company Overview
10.17.2. Product Offerings
10.17.3. Financial Performance
10.17.4. Recent Initiatives
10.18. Medical ECONET GmbH
10.18.1. Company Overview
10.18.2. Product Offerings
10.18.3. Financial Performance
10.18.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms